Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
United European Gastroenterology Journal|March 28, 2020
Validation of prognostic accuracy of MESH, HKLC, and BCLC classifications in a large German cohort of hepatocellular carcinoma patientsSophia Heinrich, Martin Sprinzl, Irene Schmidtmann, et al.
Zeitschrift Fur Gastroenterologie|January 9, 2023
Costs of a structured early detection program for advanced liver fibrosis and cirrhosis: insights on the "plus" of Check-up 35Julia Ortner, Reyn Joris Van Ewijk, Louis Velthuis, et al.
Annals of Hepatology|April 23, 2022
Characteristics of bacterial infections and prevalence of multidrug-resistant bacteria in hospitalized patients with liver cirrhosis in GermanyWolfgang Maximilian Kremer, Simon Johannes Gairing, Leonard Kaps, et al.
JHEP Reports : Innovation in Hepatology|March 3, 2023
Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosisSimon Johannes Gairing, Sven Danneberg, Leonard Kaps, et al.
United European Gastroenterology Journal|March 8, 2018
Transarterial chemoembolization versus sorafenib in patients with hepatocellular carcinoma and extrahepatic diseaseMartha M Kirstein, Torsten Voigtländer, Nora Schweitzer, et al.
Journal of Clinical Medicine|July 2, 2021
The Addition of Transarterial Chemoembolization to Palliative Chemotherapy Extends Survival in Intrahepatic CholangiocarcinomaSimon Johannes Gairing, Felix Thol, Lukas Müller, et al.
Liver Cancer|November 27, 2019
Improved Prediction of Survival by a Risk Factor-Integrating Inflammatory Score in Sorafenib-Treated Hepatocellular CarcinomaMartin F Sprinzl, Martha M Kirstein, Sandra Koch, et al.
BMJ Open|September 19, 2025
Evaluating a population-based screening programme for early detection of liver fibrosis and cirrhosis in primary care in Germany: a cost assessment studyJulia Ortner, Reyn Van Ewijk, Louis Velthuis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 11, 2019
Efficacy and safety of glecaprevir/pibrentasvir in renally impaired patients with chronic HCV infectionEric Lawitz, Robert Flisiak, Manal Abunimeh, et al.
Future Oncology (London, England)|November 24, 2025
LIVER-R study protocol: a global real-world study of durvalumab-based regimens in patients with hepatobiliary cancersMasafumi Ikeda, Marcus-Alexander Wörns, Mehmet Akce, et al.
Pageof 9